does novo nordisk have a patent on semaglutide

does novo nordisk have a patent on semaglutide New Delhi, March 19, 2026 – Friday, the key on semaglutide—the active molecule in Nordisk's blockbuster drugs Ozempic and Wegovy—expired in India, marking pivotal shift in the country's Ozempic's patent problem: how Novo

Name: does novo nordisk have a patent on semaglutide New Delhi, March 19, 2026 – Friday, the key on semaglutide—the active molecule in Nordisk's blockbuster drugs Ozempic and Wegovy—expired in India, marking pivotal shift in the country's Ozempic's patent problem: how Novo
Brand: plomberie-cannillo.fr
SKU: 34836448949
Price: 28.60 USD
Availability: InStock
Rating: 4.2646 (23 reviews)

SKU: 34836448949

4.3

EUR28.60 EUR51.60

Pay in 4 interest-free payments of $7.15 Learn more

Shipping Estimate
USA

USA

CAN

Ships within 48 hours · Estimated delivery Oct 14 - Oct 19

Description

"The US market alone could scale to $10bn within a few years as obesity rates drive demand." That would be a sizeable addition to India's pharmaceutical trade: the country's generic drug exports currently total $30.46bn, with the US already its largest market